Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Dyax says FDA wants risk strategy and other additional data on DX-88, but no new trials
Dyax says FDA wants risk strategy and other additional data on DX-88, but no new trials
Dyax says FDA wants risk strategy and other additional data on DX-88, but no new trials
Submitted by
admin
on March 27, 2009 - 7:50am
Source:
Yahoo/AP
News Tags:
Dyax
FDA
DX-88
Headline:
Dyax says FDA wants risk strategy and other additional data on DX-88, but no new trials
Do Not Allow Advertisers to Use My Personal information
